Silhouette

Elijah M Bolotin

Pharmain Corporation

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Vasoactive Intestinal Peptide for the treatment of Female Sexual Arousal Disorder
Pharmain Corporation
Principal Investigator
HHS 1 $225K 02/15/14 10/31/14
Vasoactive intestinal peptide for the treatment of psoriasis
Pharmain Corporation
Principal Investigator
HHS 1 $145K 09/01/13 08/31/14
Nanocarrier formulated enzyme for the treatment of S. aureus infection
Pharmain Corporation
Principal Investigator
HHS 1 $300K 05/01/13 04/30/14
Vasoactive intestinal peptide for the treatment of psoriasis
Pharmain Corporation
Principal Investigator
HHS 1 $227K 09/07/12 08/31/13
Nanocarrier formulated enzyme for the treatment of S. aureus infection
Pharmain Corporation
Principal Investigator
HHS 1 $300K 05/09/12 04/30/13
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
Pharmain Corporation
Principal Investigator
HHS 2 $432K 07/01/11 03/31/12
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
Pharmain Corporation
Principal Investigator
HHS 2 $351K 07/01/10 06/30/11
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
Pharmain Corporation
Principal Investigator
HHS 2 $160K 04/01/10 06/30/10
Outpatient treatment for portal hypertension
Pharmain Corporation
Principal Investigator
HHS 1 $223K 03/01/10 03/28/11
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
HHS 2 $116K 03/01/09 02/28/11
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
HHS 2 $959K 03/01/09 02/28/11
Nanocarrier with metal bridge for affinity based delivery of metal binding peptid
Pharmain Corporation
Principal Investigator
HHS 1 $184K 02/01/09 01/31/10
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
HHS 2 $61.3K 03/01/08 02/28/09
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
HHS 2 $961K 03/01/08 02/28/09
Nanocarrier with metal bridge for affinity based delivery of metal binding peptid
Pharmain Corporation
Principal Investigator
HHS 1 $200K 02/15/08 01/31/09
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
HHS 2 $915K 03/15/07 02/29/08
Targeted formulations of GLP -1 for Type 1 diabetes
Pharmain Corporation
Principal Investigator
HHS 1 $500K 09/01/05 08/31/06
Targeted formulations of GLP -1 for Type 1 diabetes
Pharmain Corporation
Principal Investigator
HHS 1 $501K 09/30/04 08/31/05